SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 45 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $13,094 | -99.8% | 7,000 | -99.9% | 0.00% | -100.0% |
| Q2 2022 | $6,162,000 | -12.0% | 4,910,000 | -7.8% | 0.11% | -2.7% |
| Q1 2022 | $7,005,000 | -30.2% | 5,328,000 | -22.3% | 0.11% | -33.7% |
| Q4 2021 | $10,032,000 | -14.9% | 6,858,000 | -14.0% | 0.17% | -22.5% |
| Q3 2021 | $11,789,000 | -19.1% | 7,970,000 | -27.8% | 0.22% | -23.0% |
| Q2 2021 | $14,567,000 | -45.9% | 11,035,000 | -46.3% | 0.28% | -51.2% |
| Q1 2021 | $26,930,000 | -17.3% | 20,563,000 | +54.5% | 0.58% | -16.4% |
| Q4 2020 | $32,575,000 | +37.6% | 13,307,000 | +16.5% | 0.69% | +33.0% |
| Q3 2020 | $23,673,000 | -13.3% | 11,418,000 | -4.3% | 0.52% | -18.4% |
| Q2 2020 | $27,313,000 | -12.4% | 11,929,000 | -41.5% | 0.64% | -5.6% |
| Q1 2020 | $31,177,000 | +195.1% | 20,376,000 | +275.3% | 0.68% | +230.7% |
| Q4 2019 | $10,564,000 | -2.2% | 5,429,000 | -33.5% | 0.20% | +1.5% |
| Q3 2019 | $10,797,000 | -11.2% | 8,161,000 | +49.6% | 0.20% | -14.0% |
| Q2 2019 | $12,160,000 | +12.7% | 5,456,000 | -8.7% | 0.24% | -1.3% |
| Q1 2019 | $10,785,000 | – | 5,974,000 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 92,999,000 | $138,298,000 | 4.13% |
| WOLVERINE ASSET MANAGEMENT LLC | 84,505,000 | $125,210,000 | 1.08% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 20,000,000 | $29,789,000 | 0.79% |
| Verition Fund Management LLC | 27,047,000 | $40,063,000 | 0.35% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 7,970,000 | $11,789,000 | 0.22% |
| Baker Brothers Advisors | 29,174,000 | $43,167,000 | 0.19% |
| Calamos Advisors LLC | 23,631,000 | $35,035,000 | 0.15% |
| RWC Asset Management LLP | 2,900,000 | $4,300,000 | 0.13% |
| Aequim Alternative Investments LP | 1,957,000 | $2,899,000 | 0.11% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,148,000 | $4,666,000 | 0.10% |